|1.||Rofstad, Einar K: 21 articles (10/2014 - 08/2004)|
|2.||Ewing, James R: 12 articles (11/2014 - 08/2003)|
|3.||Naganawa, Shinji: 10 articles (02/2011 - 03/2006)|
|4.||Nakashima, Tsutomu: 9 articles (02/2011 - 01/2008)|
|5.||Benjaminsen, Ilana C: 9 articles (11/2008 - 08/2004)|
|6.||Ellingsen, Christine: 8 articles (10/2014 - 03/2009)|
|7.||Nagaraja, Tavarekere N: 8 articles (10/2014 - 08/2003)|
|8.||Knight, Robert A: 8 articles (01/2014 - 08/2003)|
|9.||Runge, Val M: 8 articles (03/2011 - 07/2002)|
|10.||Sone, Michihiko: 8 articles (02/2011 - 01/2008)|
12/01/1988 - "In most cases, Gd-DTPA-enhanced T1-weighted spin-echo scans best delineated tumor margins, and the enhancement was helpful in suggesting a cellular or active nature of the lesions. "
05/01/1998 - "High-resolution contrast-enhanced (Gd-DTPA) dynamic MR imaging in cervical cancer offers improved tumor/cervical-stroma contrast and provides useful information on parametrial invasion."
07/01/1992 - "To investigate the efficacy of 0.025, 0.05 and 0.1 mmol/kg gadopentetate dimeglumine in MR imaging of patients with intracranial tumors at mid and high field strength. "
07/01/1990 - "We present examples of the significantly improved soft tissue contrast with Gd-DTPA T1-weighted images and discuss the improved tumor margin definition with Gd-DTPA. "
04/01/1989 - "Liposomal Gd-DTPA caused significant improvement in contrast between liver and tumor (P less than .005) on T1-weighted MR images. "
|2.||Neoplasm Metastasis (Metastasis)
08/01/1986 - "Our studies suggest a significant potential for improved detection of liver metastases with Gadolinium-DTPA-enhanced liver MRI."
04/01/1989 - "Liposomal Gd-DTPA-enhanced images permitted significant improvement in metastasis detection by five blinded radiologists (P less than .005). "
05/01/2014 - "The aim of this study was to compare the diagnostic performance of gadopentetate dimeglumine and gadoxetic-acid-enhanced MRI in patients with colorectal liver metastases. "
11/01/1996 - "The results of the study provide evidence that the use of magnevist enhances the informative value and specificity of MRT in the diagnosis of spinal metastases."
04/01/2015 - "Small numbers of brain metastases were enhancing when first detected by MRI and remained enhancing, whereas other metastases remained nonenhancing to Gd-DTPA throughout the experiment. "
|3.||Hepatocellular Carcinoma (Hepatoma)
12/01/2010 - "This study compared the efficacy of gadoxetic acid-enhanced MRI and gadopentetate dimeglumine-enhanced MRI in the detection of small hepatocellular carcinoma (HCC). "
12/01/2010 - "Diagnostic efficacy of gadoxetic acid-enhanced MRI in the detection of hepatocellular carcinomas: comparison with gadopentetate dimeglumine."
03/01/1995 - "Basic analysis of dynamic study in cases of hepatocellular carcinoma using inversion recovery snap shot FLASH MR imaging with Gd-DTPA."
02/01/2015 - "To compare gadopentetate dimeglumine and gadoxetic acid-enhanced magnetic resonance imaging (MRI) for image quality and hepatocellular carcinoma (HCC) detection/conspicuity. "
10/20/2005 - "In phantoms, in which T(1) values (44-191 msec) were assumed to be shortened by the effect of Gd-DTPA in hepatocellular carcinoma (HCC), the highest SNR in each phantom was observed at FA ranging from 15 to 30 degrees. "
|4.||Acoustic Neuroma (Acoustic Neurinoma)
03/01/1999 - "The purpose of this work was to assess the changes of signal intensity on constructive interference in steady state (CISS) 3D Fourier transformation (3DFT) MRI after administration of Gd-DTPA and to evaluate the efficacy of contrast-enhanced CISS-3DFT MRI to depict the seventh and eighth cranial nerves affected by vestibular schwannomas. "
11/01/1994 - "The current gold standard for diagnosing vestibular schwannomas is MRI with gadolinium-DTPA enhancement. "
08/01/1989 - "The use of Gd-DTPA improved the quality of the MR images by markedly enhancing the acoustic tumors in all cases. "
01/01/1988 - "Clinical advantages of Gd-DTPA include shorter scan times, macroscopic tumour/oedema separation and improved detection of certain tumours, particularly acoustic neuromas."
01/01/1992 - "The fate of tumour rests following removal of acoustic neuromas: an MRI Gd-DTPA study."
06/01/1996 - "The conspicuity of 12 of 13 carcinomas was improved in postcontrast MT-FLASH imaging enables excellent visualization of Gd-DTPA-enhancing breast lesions."
11/01/2000 - "With gadopentetate dimeglumine, the mean values for fPV and PEV were significantly greater in carcinomas (P <. "
08/01/1991 - "[The diagnosis of bladder carcinomas by NMR tomography: an improvement with Gd-DTPA?]."
06/01/2003 - "The study included 43 patients with biopsy-proven prostate carcinoma: 28 were examined by 1.0-T MRI (Turbo-FLASH) and 15 by 1.5-T MRI (FLASH) with infusion of 0.1 mmol/kg Gd-DTPA. "
05/01/1996 - "The purpose of this study is to compare the usefulness of conventional MR imaging and gadopentetate dimeglumine enhanced fat-suppressed MR imaging for the depiction and staging of rectal carcinoma. "
|1.||Gadolinium DTPA (Magnevist)
|3.||gadobenic acid (gadobenate dimeglumine)
|4.||Pentetic Acid (DTPA)